Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES et al. Photodynamic therapy with verteporfin for CNV caused by aged-related macular degeneration. Results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1177–1187.
2. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I et al. Photodynamic therapy with verteporfin for CNV caused by aged- related macular degeneration. Results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1161–1173.
3. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal CNV in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trial—TAP report 1. Arch Ophthalmol 1999; 117: 1329–1345.
4. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal CNV in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trial—TAP report 2. Arch Ophthalmol 2001; 119: 198–207.
5. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of aged related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200–1209.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献